Prostatic Diseases: all 84 studies
Page 1 of 1. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate CancerRecruitingNCT07853209Phase 3
- Study of Teverelix DP on Prostate Volume, Urinary Function and Clinical Outcomes Following Acute Urinary RetentionNot yet recruitingNCT07733934Phase 2
- A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate CancerNot yet recruitingNCT07457164Phase 2
- Exploring the Potential of Robotic Telesurgery in Remote SettingsRecruitingNCT07130708Not applicable
- A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)RecruitingNCT07103018Phase 1
- TURP Inpatient With Underactive Bladder With BOORecruitingNCT06944743Not applicable
- 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate CancerRecruitingNCT06706921Phase 4
- High Resolution Diffusion Weighted Imaging in ProstateRecruitingNCT06636747
- Talazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate CancerRecruitingNCT06582628Phase 2
- European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract SymptomsRecruitingNCT06564415
- Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)RecruitingNCT06496581Phase 3
- Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate CancerRecruitingNCT06190899Phase 1/2
- Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerRecruitingNCT05997615Phase 1
- Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for CancerRecruitingNCT05574647Not applicable
- Evaluation of the Performance of a Novel Prostate Biopsy System Compared With Standard of Care Biopsy Needle on Quantitative and Qualitative Tissue ParametersRecruitingNCT05470127Not applicable
- Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionRecruitingNCT05413850Phase 1/2
- Thulium Fiber Laser Enucleation of the Prostate (TFLEP) vs HoLEP With Moses Technology (m-HoLEP)RecruitingNCT04807296Not applicable
- Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate CancerRecruitingNCT04656678Not applicable
- MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate CancerRecruitingNCT04599218Not applicable
- Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and PainCompletedNCT05803096Phase 4Results posted
- High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical ProstatectomyTerminatedNCT04461509Phase 2Results posted
- 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)CompletedNCT03490032Phase 1/2Results posted
- Health Gatherings - For Your Health After CancerCompletedNCT03344757Not applicableResults posted
- Trial of NanoPac® Focal Therapy in Subjects With Prostate CancerCompletedNCT03077659Phase 2Results posted
- Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate CancerCompletedNCT01431391Phase 2Results posted
- Safety and Tolerability Study Using WST11 In Patients With Localized Prostate CancerCompletedNCT00946881Phase 1/2Results posted
- Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil DailyCompletedNCT00827242Phase 3Results posted
- HOP-2A - Intratesticular Hormone LevelsCompletedNCT00756561Results posted
- A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)CompletedNCT00753415Phase 1Results posted
- Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy TreatmentCompletedNCT00210249Results posted
- The Role of Butirprost® in Combination With Antibiotics in Chronic Bacterial Prostatitis (CBP) TreatmentCompletedNCT06684626Phase 3
- Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow DynamicsCompletedNCT05941260
- The Efficacy of Mapping for Cognitive Prostate BiopsyCompletedNCT05902637Not applicable
- Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPHCompletedNCT05834270Not applicable
- Clinical Investigation of the da Vinci Surgical SystemActive, not recruitingNCT05682742Not applicable
- The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological ParametersCompletedNCT05399940
- EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPCActive, not recruitingNCT05150236Phase 2
- Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy NeedleStatus unknownNCT04880681Not applicable
- 68Ga-HTK03149 for Use as a Diagnostic RadiopharmaceuticalStatus unknownNCT04831307Not applicable
- Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIAActive, not recruitingNCT04760483Phase 1
- Effect of Laser Settings on Postoperative Voiding Symptoms in Patients Undergoing Holmium Laser Enucleation of the ProstateWithdrawnNCT04699552Not applicable
- Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate CancerActive, not recruitingNCT04597411Phase 1
- A Study of FT-7051 in Men With MCRPCTerminatedNCT04575766Phase 1
- Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly DiagnosedStatus unknownNCT04462926Not applicable
- Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate CancerApproved for marketingNCT04452136
- 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI TherapyActive, not recruitingNCT04288427Not applicable
- P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)TerminatedNCT04249947Phase 1
- Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate CancerWithdrawnNCT04225299Phase 3
- MR/TRUS Fusion Guided Prostate BiopsyStatus unknownNCT04026763Not applicable
- Micro-Ultrasound/Magnetic Resonance Imaging 001CompletedNCT03938376
- Exploring the Comorbidity Between Mental Disorders and General Medical ConditionsCompletedNCT03847753
- Hypnosis Mask: a New Approach to Management of Pain in Medical ImagingCompletedNCT03711643Not applicable
- 4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic ProstatectomyWithdrawnNCT03658408Phase 2
- ConfirmMDx Assay in Multiparametric MRI (mpMRI) PIRADS Scored Lesions After a Negative MR/US Fusion BiopsyWithdrawnNCT03597386
- Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCTStatus unknownNCT03589196Not applicable
- Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation TherapyCompletedNCT03543189Phase 1/2
- Hemi-Gland Cryoablation for Prostate Cancer at UCLACompletedNCT03503643
- 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate CancerTerminatedNCT03490838Phase 1
- Biobank for African American Prostate Cancer Research in FloridaCompletedNCT03232411
- Low-energy Extracorporeal Shockwave Treatment for Patients After Radical ProstatectomyCompletedNCT03192917Not applicable
- Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate CancerCompletedNCT03104907Not applicable
- Prostatic Artery Embolization for Benign Prostatic ObstructionCompletedNCT03099421Not applicable
- Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate CancerTerminatedNCT02606123Phase 1/2
- A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc StudyCompletedNCT02578797Phase 1
- A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate BiopsyStatus unknownNCT02245334Phase 4
- Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic HyperplasiaCompletedNCT02074644Not applicable
- Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate CancerStatus unknownNCT02049190Phase 1/2
- Character Traits and Stress in Suspected Prostate CancerTerminatedNCT02031029
- Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate CancerCompletedNCT01875393Phase 3
- Radiotherapy vs Observation for CRPCStatus unknownNCT01590498
- MRI for Assessment of Hypoxia-Induced Prostate Cancer AggressivenessActive, not recruitingNCT01464216
- Glivec in Prostate Cancer Patients With Rising PSA Following Radical ProstectomyCompletedNCT01316458Phase 2
- Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.CompletedNCT01310894Phase 3
- In Vivo Dosimetry During Prostate Cancer RadiotherapyCompletedNCT01307852Phase 1
- Study Using WST11 in Patients With Localized Prostate CancerCompletedNCT00975429Phase 2
- Benign Prostatic Hyperplasia in TaiwanCompletedNCT00941343Not applicable
- Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer PatientsStatus unknownNCT00895466Phase 1/2
- Test Semiquantitative Prostate Specific Antigen (PSA)CompletedNCT00853710Not applicable
- A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)CompletedNCT00749502Phase 1
- Study of WST11 in Patients With Localized Prostate CancerCompletedNCT00707356Phase 2
- A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate CancerTerminatedNCT00672009Phase 2
- Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality StudyCompletedNCT00575913Phase 4
- Transluminal Flexible Endoscopic Procedure in Foregut and Urologic SurgeryCompletedNCT00484783Not applicable
- Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)CompletedNCT00037141Phase 1/2